Recent Posts
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
- HealthInvest September 2025
Archives
Proactive does a deep dive into AdAlta via "Combatting fibrosis"
"The smart money in medicine: combatting fibrosis"
AdAlta recently discussed with Proactive Investors how non-communicable diseases are still big game for clinical stage biotechs.
Click here
